Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis

Show other versions (1)

Objective: Interleukin 8 protein promotes inflammatory responses, even in airways. The presence of interleukin 8 gene variants causes altered inflammatory responses and possibly varied responses to inhaled bronchodilators. Thus, this study analyzed the interleukin 8 variants (rs4073, rs2227306, and...

Full description

Bibliographic Details
Main Authors:	Larissa Lazzarini Furlan, José Dirceu Ribeiro, Carmen Sílvia Bertuzzo, João Batista Salomão Junior, Dorotéia Rossi Silva Souza, Fernando Augusto Lima Marson
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Jornal de Pediatria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755717306344

Similar Items

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis
by: Larissa Lazzarini Furlan, et al.
Published: (2017-11-01)

Polymorphisms in <it>ADRB2 </it>gene can modulate the response to bronchodilators and the severity of cystic fibrosis
by: Marson Fernando A L, et al.
Published: (2012-09-01)

Cardiovascular morbidity and the use of inhaled bronchodilators
by: Christine Macie, et al.
Published: (2008-03-01)

Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
by: Fernando Augusto de Lima Marson, et al.
Published: (2013-06-01)

Pharmacotherapy of cystic fibrosis: inhaled antibiotics
by: N. I. Kapranov
Published: (2013-12-01)

Association between the IVS4G > T mutation in the <it>TCF7L2</it> gene and susceptibility to diabetes in cystic fibrosis patients
by: Furgeri Daniela, et al.
Published: (2012-10-01)

Enhancing adherence to inhaled therapies in cystic fibrosis
by: Paula Lomas
Published: (2014-04-01)

Use of inhaled tobramycin in patients with cystic fibrosis
by: A G Chermensky, et al.
Published: (2010-08-01)

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
by: Elizabeth Claire Elson, et al.
Published: (2019-04-01)

Oral health in patients with cystic fibrosis
by: Aline Cristina Gonçalves, et al.
Published: (2018-11-01)

Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis
by: Aline Cristina Gonçalves, et al.
Published: (2019-07-01)

Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis
by: Aline Cristina Gonçalves, et al.
Published: (2019-07-01)

Mutações do gene cystic fibrosis transmembrane conductance regulator e deleções dos genes glutationa S-transferase em pacientes com fibrose cística no Brasil Cystic fibrosis transmembrane conductance regulator gene mutations and glutathione S-transferase null genotypes in cystic fibrosis patients in Brazil
by: Carmen Silvia Passos Lima, et al.
Published: (2012-02-01)

Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
by: Xiaoxuan Han, et al.
Published: (2023-05-01)

Inhaled therapy in cystic fibrosis: agents, devices and regimens
by: Penny Agent, et al.
Published: (2015-06-01)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
by: Cheng S, et al.
Published: (2017-07-01)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
by: José Alberto Neder, et al.

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O.I. Simonova, et al.
Published: (2011-05-01)

INHALATION ANTIBIOTICS ARE ESSENTIAL FOR THE CONTROL OF INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O.I. Simonova, et al.
Published: (2011-01-01)

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
by: Martha K Daddario, et al.
Published: (2010-10-01)

Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin
by: Anne M. Akkerman-Nijland, et al.
Published: (2020-02-01)

Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
by: Julie Ann Justo, et al.
Published: (2013-10-01)

Prerequisites for a dry powder inhaler for children with cystic fibrosis.
by: Anne J Lexmond, et al.
Published: (2017-01-01)

The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis
by: Safka Katherine, et al.
Published: (2008-12-01)

Prevalência da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator em pacientes com fibrose cística em um centro de referência no Brasil
by: Andréia Marisa Bieger, et al.
Published: (2012-12-01)

The <it>ACE</it> gene D/I polymorphism as a modulator of severity of cystic fibrosis
by: Marson Fernando A L, et al.
Published: (2012-08-01)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01)

Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
by: S.I. Ilchenko, et al.
Published: (2022-09-01)

Evidence for the efficacy of aztreonam for inhalation solution in the management of in patients with cystic fibrosis
by: Christine Hansen, et al.
Published: (2015-02-01)

Nebulization metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study
by: Rongli Lu, et al.
Published: (2023-12-01)

Effective treatment of inhaled corticosteroid and bronchodilator for “lymphocytic interstitial pneumonia” in primary Sjögren's syndrome
by: Yuki Moriuchi, et al.
Published: (2024-01-01)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
by: Kostikas Konstantinos, et al.
Published: (2010-09-01)

Successes and Challenges: Inhaled Treatment Approaches Using Magnetic Nanoparticles in Cystic Fibrosis
by: Marsha Tan, et al.
Published: (2020-06-01)

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging
by: Carsten Schwarz, et al.
Published: (2021-12-01)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
by: Lesley Uttley, et al.
Published: (2013-12-01)

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
by: Chorepsima S, et al.
Published: (2018-11-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

The future of bronchodilation: looking for new classes of bronchodilators
by: Mario Cazzola, et al.
Published: (2019-12-01)